A detailed history of Schroder Investment Management Group transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 211,274 shares of NBIX stock, worth $28.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
211,274
Previous 185,384 13.97%
Holding current value
$28.9 Million
Previous $25.5 Million 4.69%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $2.97 Million - $3.97 Million
25,890 Added 13.97%
211,274 $24.3 Million
Q2 2024

Aug 12, 2024

BUY
$130.86 - $143.19 $4.61 Million - $5.05 Million
35,257 Added 23.48%
185,384 $25.5 Million
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $9.73 Million - $10.7 Million
74,592 Added 98.75%
150,127 $20.7 Million
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $1.9 Million - $2.38 Million
17,931 Added 31.13%
75,535 $9.95 Million
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $534,879 - $666,181
-5,689 Reduced 8.99%
57,604 $6.48 Million
Q2 2023

Aug 11, 2023

BUY
$89.53 - $104.87 $667,088 - $781,386
7,451 Added 13.34%
63,293 $5.97 Million
Q1 2023

May 11, 2023

BUY
$94.11 - $123.02 $4.59 Million - $5.99 Million
48,729 Added 685.07%
55,842 $5.65 Million
Q4 2022

Feb 10, 2023

SELL
$106.72 - $127.06 $354,203 - $421,712
-3,319 Reduced 31.82%
7,113 $849,000
Q3 2022

Nov 10, 2022

BUY
$92.03 - $107.81 $960,056 - $1.12 Million
10,432 New
10,432 $1.11 Million
Q4 2019

Feb 11, 2020

SELL
$86.8 - $118.57 $276,024 - $377,052
-3,180 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$83.82 - $101.5 $23,301 - $28,217
278 Added 9.58%
3,180 $287,000
Q2 2019

Aug 08, 2019

SELL
$72.24 - $91.27 $814,433 - $1.03 Million
-11,274 Reduced 79.53%
2,902 $245,000
Q1 2019

May 14, 2019

BUY
$69.31 - $91.53 $377,046 - $497,923
5,440 Added 62.27%
14,176 $1.25 Million
Q4 2018

Feb 14, 2019

SELL
$68.32 - $124.36 $697,820 - $1.27 Million
-10,214 Reduced 53.9%
8,736 $624,000
Q3 2018

Nov 13, 2018

SELL
$98.88 - $125.85 $548,685 - $698,341
-5,549 Reduced 22.65%
18,950 $2.33 Million
Q1 2018

May 11, 2018

SELL
$75.88 - $92.43 $339,714 - $413,809
-4,477 Reduced 15.45%
24,499 $2.03 Million
Q4 2017

Feb 09, 2018

SELL
$58.53 - $77.59 $475,790 - $630,729
-8,129 Reduced 21.91%
28,976 $2.25 Million
Q3 2017

Nov 09, 2017

BUY
$47.97 - $61.28 $1.78 Million - $2.27 Million
37,105
37,105 $2.2 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.